/
/
/

Indo US Bio-Tech Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022
₹33 Cr₹26 Cr₹23 Cr₹31 Cr₹31 Cr₹33 Cr₹24 Cr₹22 Cr₹25 Cr₹16 Cr₹22 Cr₹16 Cr₹19 Cr₹18 Cr₹16 Cr₹14 Cr₹14 Cr
₹12 L₹2 L₹50,000₹3 L₹20,000₹12 L₹2 L₹2 L₹3 L₹21 L₹8 L₹30,000₹3 L₹2 L₹30,000₹0₹0
₹33 Cr₹26 Cr₹23 Cr₹31 Cr₹31 Cr₹34 Cr₹24 Cr₹22 Cr₹25 Cr₹16 Cr₹22 Cr₹16 Cr₹19 Cr₹18 Cr₹16 Cr₹14 Cr₹14 Cr
₹29 Cr₹23 Cr₹19 Cr₹27 Cr₹25 Cr₹29 Cr₹18 Cr₹17 Cr₹21 Cr₹15 Cr₹18 Cr₹13 Cr₹16 Cr₹15 Cr₹14 Cr₹12 Cr₹12 Cr
₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹1 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr
₹74 L₹60 L₹77 L₹42 L₹45 L₹26 L₹38 L₹52 L₹33 L₹36 L₹37 L₹41 L₹37 L₹27 L₹41 L₹17 L₹29 L
₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹63 L₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr
₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹52 L₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹2 Cr

Share Price Live Stats

Open (₹)77.02
Volume (₹)41,730.00
High (₹)79.78
Upper Circuit94.58
Low (₹)70.00
Lower Circuit63.06
Prev Close78.82
52W High (₹)159.00
Price77.20
52W Low (₹)70.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)162.68 Cr
Div. Yield (%)0.00
PE Ratio14.20
Debt to Equity0.19
Price to Book3.76
Book Value39.16
EPS (TTM)5.71
Face Value10.00
ROE (%)23.03

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
BSHSLNSE
REGAALNSE
MGEL-BENSE
SHEETAL-SMNSE
KOTYARK-BENSE
NATHBIOGENNSE
INDOUSNSE
LTP
1W Low
1W High
Market cap (₹)
744.1-42.7 (-5.43%)
735.95
790
3,837Cr
1663.8+91.9 (5.85%)
1575.40
1747.40
2,362Cr
91.02+5.83 (6.84%)
84.60
97
1,394Cr
423.75-15.15 (-3.45%)
417.80
477.95
1,033Cr
90.81-1.04 (-1.13%)
88.10
94.20
931Cr
88.29-4.22 (-4.56%)
85.45
94.47
919Cr
14.49+0.04 (0.28%)
13.90
14.75
477Cr
348.1+8.3 (2.44%)
332
352
408Cr
33.76-1.04 (-2.99%)
30.05
34.34
364Cr
153.1-4.2 (-2.67%)
151.66
160.39
293Cr
77.2-3.71 (-4.59%)
70
84.27
163Cr

Key Highlights of Indo US Bio-Tech Ltd’s P&L

In 2022-03-31, Indo US Bio-Tech Ltd reported total revenue of ₹50.24Cr, compared with ₹40.15Cr in 2021-03-31, reflecting Indo US Bio-Tech Ltd turnover.

Depreciation was ₹44.61Lakh and finance costs were ₹1.2Cr in 2022-03-31

Profit Before Tax (PBT) has been ₹5.31Cr in 2022-03-31 as compared to ₹3.93Cr in 2021-03-31.

Net Profit (PAT) was ₹5.06Cr in 2022-03-31 compared with ₹4.9Cr in 2021-03-31.

Earnings per share (EPS) were ₹5.52 in 2022-03-31, compared with ₹8.07 in 2021-03-31.